RETRACTED: Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG-63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial-mediated apoptosis (Retracted article. See vol. 25, 2023)

被引:38
作者
Du, Guang-Yu [1 ]
He, Sheng-Wei [1 ]
Zhang, Lu [1 ]
Sun, Chuan-Xiu [1 ]
Mi, Li-Dong [1 ]
Sun, Zue-Gang [1 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 2, Dept Bone Surg, 467 Zhongshan Rd, Dalian 116023, Liaoning, Peoples R China
关键词
apoptosis; osteosarcoma; hesperidin; flow cytometry; cell cycle; CANCER; THERAPY; CHEMOTHERAPY; FLAVONOIDS;
D O I
10.3892/ol.2018.9439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of the present study was to investigate the anticancer properties of hesperidin against human osteosarcoma MG-63 cells. Its effects on apoptosis, cell migration, cell invasion and cell cycle arrest, and its effects on tumor volume and weight were also evaluated in the present study. MTS assay was used to study the cytotoxic effects of the compound on cell viability. Effects on apoptosis and cell cycle arrest were evaluated by flow cytometry. In vitro wound healing assay and Matrigel assay were performed to study the effects of hesperidin on cell migration and cell invasion, respectively. Hesperidin exerted dose-dependent and time-dependent growth inhibitory effects on cervical cancer cells with IC50 values of 33.5, 23.8 and 17.6 mu M, respectively, at 24, 48 and 72 h time intervals. Hesperidin led to early and late apoptosis induction in these cells. Hesperidin-treated cells also led to G2/M phase cell cycle arrest, which exhibited strong dose-dependence. Hesperidin treatment also led to inhibition of cell migration and invasion.
引用
收藏
页码:6299 / 6306
页数:8
相关论文
共 22 条
[1]   Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[2]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[3]   Treatment of osteosarcoma at first recurrence after contemporary therapy - The Memorial Sloan-Kettering Cancer Center Experience [J].
Chou, AJ ;
Merola, PR ;
Wexler, LH ;
Gorlick, RG ;
Vyas, YM ;
Healey, JH ;
LaQuaglia, MP ;
Huvos, AG ;
Meyers, PA .
CANCER, 2005, 104 (10) :2214-2221
[4]   Chemotherapy resistance in osteosarcoma: current challenges and future directions [J].
Chou, Alexander J. ;
Gorlick, Richard .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (07) :1075-1085
[5]   Therapy for osteosarcoma: Where do we go from here? [J].
Chou A.J. ;
Geller D.S. ;
Gorlick R. .
Pediatric Drugs, 2008, 10 (5) :315-327
[6]   THE PHARMACOLOGY, METABOLISM, ANALYSIS, AND APPLICATIONS OF COUMARIN AND COUMARIN-RELATED COMPOUNDS [J].
EGAN, D ;
OKENNEDY, R ;
MORAN, E ;
COX, D ;
PROSSER, E ;
THORNES, RD .
DRUG METABOLISM REVIEWS, 1990, 22 (05) :503-529
[7]   Current treatment of osteosarcoma [J].
Ferguson, WS ;
Goorin, AM .
CANCER INVESTIGATION, 2001, 19 (03) :292-315
[8]   Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen plus ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo [J].
Finlan, LE ;
Kernohan, NM ;
Thomson, G ;
Beattie, PE ;
Hupp, TR ;
Ibbotson, SH .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (05) :1001-1010
[9]   Synthesis of novel benzofurocoumarin analogues and their anti-proliferative effect on human cancer cell lines [J].
Francisco, Carla S. ;
Rodrigues, Ligia R. ;
Cerqueira, Nuno M. F. S. A. ;
Oliveira-Campos, Ana M. F. ;
Rodrigues, Ligia M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 47 :370-376
[10]  
Galati G, 2000, Drug Metabol Drug Interact, V17, P311